🟣Digestive Health Manifesto 👉https://eosnetwork.org/News/ueg-digestive-health-manifesto-2025 A call for stronger patient involvement in cancer care, PROMs & clinical trials. 🤝@myueg.bsky.social @digestivecancerseu.bsky.social @pce-europe.bsky.social #digestivehealth #EUNewsline #EGID

PCE is proudly participating in the European Cancer Summit 2025 this week, joining colleagues, partners, and leaders from across Europe to advance our shared mission of improving pancreatic cancer care and outcomes. @europeancancer.bsky.social

In the afternoon sessions, we discuss work packages 1 – 3, first each progress separately, then jointly in a planum discussion. 1️⃣ Patient cohorts & sample collection 2️⃣ #liquidbiopsy diagnostis 3️⃣ AI analysis & data management #PancSky

CT don’t just shape the future of cancer care, they can also make a difference today. Today’s question: Can a trial help me now or only in the future? Sometimes both! CT explore new treatments that may help patients receiving care, while also generating knowledge that benefits future patients.

Bonjour and goedendag from Brussels! Our 4th PANCAID General Assembly Meeting just kicked off with a masterclass shared by Klaus Pantel and Catherine Alix-Panabieres, on #Liquidbiopsy diagnostics #pancreaticcancer @cathiepana.bsky.social

We just had our PANCAID ECS session, where each ECS gave an update on their individual research projects. Thank you to Ebba Asplund, Kim-Lea Reese, Robert Wittram, Pabolo Villoslada-Blanco, Sergio Sabroso and Mireia Andueza for your presentations and contributions! #pancreaticcancer #earlydetection

This week in our World Pancreatic Cancer Awareness Month series on clinical trials, we’re looking at another important question patients often ask: 🔍 Do patients get help in a trial? ✅ Yes. Doctors and nurses take special care of people taking part in clinical trials to keep them safe.

Today, we’re moving to another important question many people have: 🔍 Are clinical trials safe? Clinical trials follow strict regulations to protect participants. Importantly, patients can stop taking part at any time if they wish.

Who can join a clinical trial? 🟣 People with cancer may join if they meet certain criteria like age, cancer type, stage & overall health. Talk to your doctor to learn if a trial is right for you.

Who can join a clinical trial? 🟣 People with cancer may join if they meet certain criteria like age, cancer type, stage & overall health. Talk to your doctor to learn if a trial is right for you.

Have you registered? PCE, in collaboration with the European Pancreatic Club invites you to a webinar on how clinical trials are shaping the future of pancreatic cancer care. 🗓 27 Nov 🕞 15:30–17:00 CET 🔗 Register by 27 Nov, 12:00 CET: forms.gle/eeAuHddabv7z...

Why are clinical trials important in #PancreaticCancer? Because every new treatment, every improved therapy, and every survival gain starts with a clinical trial. Without them, progress stops. 🔁 Please like, share or comment to raise awareness.

🟣 What is a clinical trial? It’s a research study that tests new drugs or treatments to see if they are safe and effective. Every cancer treatment used today began as a clinical trial. Follow along this month as we answer more questions.  #WorldPancreaticCancerMonth #ClinicalTrials #PCE

PCE took part in the 2nd Botton-Champalimaud International Pancreatic Cancer Conference from 29 October to 1 November. Our Secretariat, Luisa Pagano, presented PCE’s work on patient advocacy and research support, and introduced our 10th Anniversary campaign.

📢 Continuing the Momentum for Pancreatic Cancer Across Europe 👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy

Together, we’re advancing pancreatic cancer care across Europe. 🌍 Since the #PancreaticCancer Position Paper was published in May 2024, we’ve been turning its recommendations into action – improving prevention, early detection & care. 👉 Learn more: https://bit.ly/3JzYNiC#PancreaticCancer #EUNewsline

Since the publication of the Pancreatic Cancer Across Europe Position Paper in May 2024, our partner organisations have continued working to turn its recommendations into tangible progress. Read the full update on what has been achieved so far: shorturl.at/pod8H

November is Pancreatic Cancer Awareness Month, a time to raise awareness and take action. 💜 This year, we’re focusing on Clinical Trials 🔬, key to new treatments and hope for patients. Stay tuned for our Q&A series!

PCE is proud to be a member of the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA), a pioneering initiative that unites leading experts from across the globe. Learn more:

A pancreatic cancer diagnosis affects not only the body but also the mind. 🧠 Through our Emotional Support and Pancreatic Cancer Project, we aim to make mental health a core part of cancer care. 👉 Find useful resources here: pancreaticcancereurope.eu/project/emot...

Join us together with @cancerpatientseu.bsky.social on Tuesday, 14 October 2025, from 15:30 to 17:00 CET for the online webinar “The Role of EU HTA in National Healthcare: Bridging Policy and Patient Access.” Find out more and register: pancreaticcancereurope.eu/project/the-...

Supporting @pce-europe.bsky.social during #UEGWeek @myueg.bsky.social

We were delighted to welcome Professor Matthias Löhr, President of @myueg.bsky.social to the PCE booth during #uegweek 2025! Thank you, Professor Löhr, for your continuous support and commitment to improving outcomes for people affected by pancreatic cancer. 💪💜

Don’t miss DiCE CEO Zorana Maravic speaking today from ⏰ 15:00 to 16:00 at the Patient Leaders Section, together with @pce-europe.bsky.social and the European Coalition for People Living with Obesity, in the @myueg.bsky.social Community Area!

Our Secretariat Lucia Colonna & Assistant Anna Ripa di Meana are proudly representing PCE at #UEGWeek 2025! 💜 Join us later at 15:00–16:00 for the first “Meet the Patient Organisations!” session — amplifying the patient voice. Learn more: pancreaticcancereurope.eu

The PCE Secretariat – Lucia Colonna and Secretariat Assistant Anna Ripa di Meana are on their way to Berlin for #uegweek 2025! We’re looking forward to connecting with the community as we continue working together to improve outcomes for pancreatic cancer patients across Europe. 💜

👉 discern.iarc.who.int @ikccorg.bsky.social @pce-europe.bsky.social

Through the EU-funded DISCERN project, DiCE is helping to shed light on colorectal cancer. By deepening our understanding of colorectal cancer and its distribution across Europe, DISCERN is paving the way for more effective prevention and, ultimately, better outcomes for patients.

#DidYouKnow that each tumour has its own biology & biomarkers can help to reveal its specific characteristics? On #WorldmCRCDay, people living with mCRC share how biomarker testing changed their care journey. Learn more➡️ digestivecancers.eu/biomarkers-i... #KnowYourBiomarkers @fightcrc.bsky.social

🟣 Did you know? Promising projects like PANCAID are paving the way in pancreatic cancer research. By working to identify biomarkers through a simple blood test, they aim to enable earlier screening of at-risk groups.

Congratulations to Belén Toledo, winner of the 2025 Short-term Scientific Stay Award! She will join Prof. Pedro Real at GENYO to advance pancreatic cancer research. 👉 Watch the full interview here: youtu.be/efajKnJK7Fc

🟣 Did you know? About 70% of pancreatic cancers develop in the head of the organ, in most cases originating in the ducts that carry digestive enzymes. 👉 Learn more: https://pancreaticcancereurope.eu #pancreaticcancer

PCE is pleased to announce a new collaboration with OncoSil Medical as part of the Treatment Opportunities for Pancreatic Cancer project. Learn more here: pancreaticcancereurope.eu/news/pancrea...

Join our webinar “The Role of EU HTA in National Healthcare: Bridging Policy & Patient Access” on 14 Oct 2025, 15:30–17:00 CEST. Experts, policymakers & patients will discuss EU HTA’s impact on access to innovation. Register here: forms.gle/RxkJF1e5Dq5H...

🟣 Did you know? Pancreatic cancer symptoms can be remarkably subtle, often leading people to overlook them! This underlines the importance of paying attention to even the smallest changes in your health. Early detection could make all the difference! 🔗 Learn more: https://pancreaticcancereurope.eu

🟣 Did you know? Studies reveal a striking link between diabetes and pancreatic cancer. Individuals with diabetes are at a significantly higher risk of developing this aggressive form of cancer. 🔗 Learn more: https://pancreaticcancereurope.eu #pancreaticcancer

PCE is proud to launch our new donation campaign. Every contribution helps us raise awareness, support patients and families across EU. By donating, you will help us continue providing information and resources to people affected by pancreatic cancer. https://pancreaticcancereurope.eu/donate/

At PCE, we’re proud to present our interactive Research Map, showcasing pancreatic cancer research groups across Europe. 📍 Explore now: research-groups.pancreaticcancereurope.eu #pancreaticcancer #pancreaticcancerawareness #fightpancreaticcancer #pancreaticcancersupport #pancreaticcancerresearch

Become a part of our network of organisations and individual members from across Europe and beyond! Visit our website at https://pancreaticcancereurope.eu/members/ to learn more about how you can become a member and contribute to our shared cause. 💜

🟣 Did you know? There is currently no standard screening test for pancreatic cancer, making public awareness and early symptom recognition even more critical. By knowing the signs and sharing knowledge, we can save lives. 🔗 Learn more: https://pancreaticcancereurope.eu

🟣 Did you know? Despite its small size, the pancreas is one of the most active and essential organs in your body — it works every time you eat, even a snack. Keeping it healthy is key to your overall wellbeing. 🔗 Learn more: https://pancreaticcancereurope.eu

PCE and Cancer Patients Europe invite you to our webinar, The Role of HTA in National Healthcare: Bridging Policy and Patient Access, on 14 October 2025 from 15:30–17:00 CEST. Save the date and join us online for this vital discussion. #HTA #PatientAccess

As part of our initiative in Belgium, supported by the Lotterie Nationale, we’re sharing multilingual resources to help the public recognise the 10 warning signs of pancreatic cancer. Early diagnosis can save lives. Access here: pancreaticcancereurope.eu/projects-and...

At PCE, we believe early detection saves lives. We're supporting PANSCREEN, a Belgian study exploring screening for those at higher risk of pancreatic cancer. If you or a loved one is affected, please complete their short survey and share your views. #PANSCREEN

🎥 PCE had the opportunity of meeting Amy de Haar-Holleman, Medical Oncologist at UZ Brussel and Clinical Professor at Vrije Universiteit Brussel, Belgium. Watch the full interview here: https://youtu.be/BrdIRz78oUI #PancreaticCancerAwareness #PancreaticCancer #PancreaticCancerEurope

🟣 Did you know? Your pancreas produces about 1.5 litres of digestive juices every day to help break down proteins, fats, and carbohydrates in your food. This powerful little organ is working hard behind the scenes every time you eat. 🔗 Learn more: https://pancreaticcancereurope.eu

PCE had the honour of speaking with Frances Drummond, Head of Research at Breakthrough Cancer Research in Ireland. In this short interview, She shares why investment in research is essential to improve outcomes for pancreatic cancer. Watch the full interview here: https://youtu.be/epoqPjZ1M2g

PCE recently spoke with Ferdinando Chiaradonna, Full Professor at Università degli Studi di Milano-Bicocca. 📽️ Watch the full interview here: https://youtu.be/A9D4gv2hEBo

🎤 At the 57th European Pancreatic Club Meeting in Düsseldorf, PCE was proud to co-host a successful joint session with the Anticancer Fund on "Bridging the gap: From preclinical discoveries to clinical trials in pancreatic cancer."

Today at the 57th European Pancreatic Club - EPC Meeting in Düsseldorf, Germany, our PancreOS Project Officer, Raquel Benítez Dorta, presented the PancreOS project during the poster session chaired by Caroline Verbeke.